Exicure (XCUR) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free XCUR Stock Alerts $0.50 -0.01 (-1.96%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineExicure faces Nasdaq non-compliance over delayed filinginvesting.com - April 24 at 5:47 PMExicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Kbusinesswire.com - April 22 at 4:01 PMExicure (NASDAQ:XCUR) Shares Down 8.7% americanbankingnews.com - April 18 at 1:34 AMExicure Stock (NASDAQ:XCUR), Short Interest Reportbenzinga.com - February 22 at 7:55 AMWhy FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Sessionbenzinga.com - February 6 at 2:15 PMWhy Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarketmsn.com - February 6 at 9:44 AMExicure Inc Announces Licensing Patents for Therapeutic Advancementmsn.com - February 6 at 9:15 AMExicure, Bluejay Therapeutics Enter Patent License Agreement to Develop Hepatitis Treatmentmarketwatch.com - February 5 at 5:22 PMExicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitisfinance.yahoo.com - February 5 at 5:22 PMBest Undervalued Stocks for February 2024msn.com - February 1 at 1:04 PMExicure, Inc. (XCUR) Stock Price, News, Quote & History - Yahoo Financeca.finance.yahoo.com - December 16 at 8:49 AMWhy Is Exicure (XCUR) Stock Up 57% Today?investorplace.com - December 8 at 10:01 AMExicure receives Nasdaq delinquency notice on late filing of its form 10-Qmsn.com - November 28 at 5:18 PMExicure Inc XCURmorningstar.com - November 9 at 1:25 PMLacklustre Performance Is Driving Exicure, Inc.'s (NASDAQ:XCUR) 25% Price Dropfinance.yahoo.com - August 29 at 7:04 AMExicure names new CEO, CFO, directors in wake of resignationsmsn.com - August 23 at 4:05 PMExicure First Half 2023 Earnings: US$1.38 loss per share (vs US$3.71 loss in 1H 2022)finance.yahoo.com - August 15 at 7:28 AMExicure: Substantial Financing Needed to Continue Operationsmarketwatch.com - August 11 at 5:38 PMExicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate Updatebusinesswire.com - August 11 at 5:38 PMExicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - July 14 at 6:09 PMExicure board backs CEO Kim's strategic alternative view for companymsn.com - May 26 at 5:52 PMExicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternativesfinance.yahoo.com - May 26 at 5:52 PMExicure, Inc. (XCUR) stock price, news, quote & history – Yahoo Financesg.finance.yahoo.com - May 25 at 9:51 AMExicure gets Nasdaq non-compliance notice for not filing 10-Qseekingalpha.com - May 19 at 5:13 PMExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directorsfinance.yahoo.com - April 27 at 7:59 AMExicure Warns of Need to Raise Additional Funds to Keep Operatingwsj.com - March 28 at 6:11 AMExicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - March 28 at 6:11 AMExicure (XCUR) Earnings Dates & Reportsinvesting.com - March 20 at 5:54 PMExicure, Inc. (XCUR) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 15 at 10:16 PMExicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Updateca.finance.yahoo.com - November 15 at 7:14 AMExicure Warns of Needing Bankruptcy Protection if Deal with CBI USA Failsmarketwatch.com - November 15 at 7:14 AMmarketbeat.com - November 14 at 4:03 PMExicure Lays Off Two-Third Employees, Ceases R&D Activitiesfinance.yahoo.com - September 28 at 11:11 AMJabil, TD Synnex And 3 Stocks To Watch Heading Into Tuesday By Benzinga - Investing.com UKuk.investing.com - September 27 at 1:48 PMExicure shares are trading higher after the company announced a workforce reduction and a private placeme - Benzingabenzinga.com - September 26 at 10:45 PMAfter-Hours Movers: Nautilus Gains on Strategic Review By Investing.com - Investing.cominvesting.com - September 26 at 6:48 PMExicure to get $5.4M equity financing, reduce workforce & end R&D, preclinical activities - Seeking Alphaseekingalpha.com - September 26 at 5:45 PMExicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives - Business Wirebusinesswire.com - September 26 at 5:45 PMmarketbeat.com - September 26 at 4:06 PMXCUR.N - Exicure Inc | Stock Price & Latest News | Reutersreuters.com - September 25 at 12:53 AMXCUR.OQ - Exicure Inc | Stock Price & Latest News | Reutersreuters.com - September 15 at 9:08 PMExicure Announces Presentation at Chardan's 6th Annual Genetic Medicines Conference - Business Wirebusinesswire.com - September 1 at 7:17 AMWhy Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket - msnNOWmsn.com - August 30 at 10:16 AMExicure (XCUR) Investor Presentation - Slideshowseekingalpha.com - August 18 at 7:20 PMChardan Adjusts Exicure's Price Target to $2 on 1-for-30 Reverse Stock Split, Maintains Neutral Rating - Marketscreener.commarketscreener.com - August 16 at 12:32 PMExicure, Inc. Reports Second Quarter 2022 Financial Results and Corporate Progress - Business Wirebusinesswire.com - August 16 at 4:33 AMExicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement - Benzinga - Benzingabenzinga.com - July 22 at 10:50 AMExicure regains compliance with Nasdaq's minimum bid price requirement - Seeking Alphaseekingalpha.com - July 20 at 5:22 PMExicure, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirementfinance.yahoo.com - July 20 at 5:22 PMExicure files shelf registration of common stock for holders - Seeking Alphaseekingalpha.com - July 12 at 7:42 AM Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. XCUR Media Mentions By Week XCUR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XCUR News Sentiment▼0.180.32▲Average Medical News Sentiment XCUR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XCUR Articles This Week▼30▲XCUR Articles Average Week Get Exicure News Delivered to You Automatically Sign up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alzamend Neuro News Oragenics News Seelos Therapeutics News Kineta News Sonnet BioTherapeutics News China Pharma News GT Biopharma News LumiraDx News Synaptogenix News Bright Minds Biosciences News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XCUR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
